Explore our market-ready, standard and specialized OEM/ODM dosage solutions, produced under strict cGMP and SQF Edition 9 standards.
Premium Grade OEM/ODM thickener formulation offering superior viscosity control and clear stability for advanced liquid formulations.
Fully integrated R&D and automated formulation system tailored for complex microencapsulation and batch scaling.
Standardized botanical extract powder engineered for enhanced flowability, stability, and encapsulation in hard capsules or tablets.
Clean-label vegan protein blends optimized for rapid dispersion, smooth mouthfeel, and customized micronutrient fortification.
High-grade tailored compound formulations delivering exceptional thermal stability and dispersion consistency for specialized manufacturing.
Pectin-based microencapsulated fatty acid delivery system eliminating oxidation and fishy taste, zero synthetic additives.
Precision-dosed, highly bioavailable creatine chewables engineered for stable shelf-life and enhanced muscle uptake.
GMP-certified green chlorophyll extract pectin gummies formulated with stabilized natural color matrix and natural flavor profiles.
We eliminate manufacturing bottlenecks, technical instability, and regulatory risk through fully integrated global infrastructure.
Operating under strict US 21 CFR Part 111 (Dietary Supplement cGMP) and Part 117 (Preventive Controls for Human Food), backed by SQF Edition 9 certification. Complete batch genealogy and analytical validation on every run.
From product brief and R&D bench sampling to stability testing and full cGMP commercial run—our synchronized workflow gets custom encapsulation products to market in exactly 90 days.
Headquartered in Springville, Utah for North American supply chain resilience, supported by an EU-GMP site in the Netherlands and high-capacity manufacturing operations in Shenzhen for optimized sourcing leverage.
In the modern health, dietary supplement, and specialized chemical sectors, ingredient performance is no longer defined solely by raw material purity. It is determined by physical delivery systems, bio-accessibility profiles, and chemical stability. Encapsulation technology—spanning microencapsulation, liposomal lipid carriers, enteric coated matrices, and advanced softgel/gummy polymer entrapment—has emerged as the paramount differentiator for brand owners seeking defensible IP and real-world efficacy.
As a leading OEM/ODM custom encapsulation supplier, PAG Pharmatech America LLC provides contract development and manufacturing organization (CDMO) services engineered to solve complex formulation challenges: protecting shear-sensitive actives, masking noxious botanical tastes, preventing early gastrointestinal degradation, and ensuring precise dissolution kinetics.
Strategic Technical Insight: Over 64% of botanical extracts and lipophilic nutrients lose up to 40% of active potency due to oxidation or gastric breakdown when unencapsulated. Advanced microencapsulation matrices preserve active potency throughout shelf-life.
Our Springville, Utah facility utilizes five core encapsulation and processing technologies, customizable for private label brands and enterprise formulation systems:
Micro-encapsulation of particles using enteric or lipid polymers to control release sites and isolate reactive ingredients.
Liquid-to-powder conversion encapsulating volatile oils, flavorants, and hydrophobic botanicals into water-dispersible matrices.
Phospholipid bilayer structures engineered for maximum cellular uptake of hydrophobic compounds like Omega-3s and CoQ10.
Thermal-stable gummy deposit systems preventing thermal degradation of active botanical and vitamin loads during casting.
Procurement teams across global health brands face evolving consumer expectations, regulatory scrutiny, and supply chain vulnerabilities. When selecting an OEM/ODM encapsulation manufacturer, purchasing directors must align with four structural market shifts:
Standard bovine gelatin capsules are rapidly giving way to non-GMO Hydroxypropyl Methylcellulose (HPMC), pullulan, and modified seaweed pectin shells. Buyers require CDMO partners capable of filling heat- and moisture-sensitive powders into vegetable casings without sacrificing high-speed machine throughput.
Single-ingredient formulations are losing market share to complex synergy stacks. Procurement trends favor suppliers capable of dual-beadlet encapsulation, oil-and-powder combo capsules, or dual-layer gummies that keep incompatible active ingredients separate until ingestion.
With updated FDA cGMP enforcement regarding 21 CFR Part 117 preventive controls, enterprise buyers must audit raw material supply chains for heavy metals, ethylene oxide (EtO) residues, pesticide screens, and microbial counts. Every production run at PAG Pharmatech includes complete Certificate of Analysis (CoA) documentation verified by ISO 17025 accredited testing laboratories.
Global logistics disruptions have demonstrated the risk of single-source overseas procurement. Brands targeting North American markets are prioritizing US-based FDA-registered facilities to secure 8 to 12-week turnarounds while leveraging global manufacturing footprints for international expansion.
To capture market share in competitive channels—such as Amazon, TikTok Shop, specialty retail, and direct-to-consumer (DTC) platforms—formulators must utilize cutting-edge encapsulation trends:
Below are essential technical and commercial responses for procurement managers evaluating PAG Pharmatech as their OEM/ODM custom encapsulation contract manufacturer.
Our minimum order volumes are designed to support both rapid growth brands and enterprise scale-up runs: 6,000 units for custom gummies; 5,000 units for hard capsules, softgels, and compressed tablets; and 300 kg for custom powder blends or stick packs. Pet nutrition soft chews start at 2,000 units.
Our standardized CDMO execution process achieves market readiness within 90 days. R&D bench prototyping and flavor formulation take 2–3 weeks; analytical stability and pilot verification take 3–4 weeks; full commercial cGMP production and QA batch release complete within the remaining timeframe. Private label programs utilizing validated stock base formulas ship in as few as 8 to 10 weeks.
Yes. All North American production takes place in our Springville, Utah plant, which is FDA-registered under 21 CFR Part 111 (Dietary Supplements) and Part 117 (Food Safety). We hold third-party SQF Edition 9, cGMP, Halal, Kosher, and USDA Organic handling credentials. Full compliance documentation packages are shared under NDA during supplier qualification.
Every shipped batch is accompanied by a full QA Release Package including: a comprehensive Certificate of Analysis (CoA) for potency, heavy metals, microbial panel, and physical specifications; Batch Production Records (BPR); Allergen Statements; Specification Sheets; and retained samples stored in climate-controlled archives.
Absolutely. We regularly execute technology transfers for established supplement companies. Our technical operations team reviews your Master Batch Record (MBR), qualifies equivalent raw materials, conducts scale-up trial runs, and matches your exact physical and dissolution profiles while lowering lead times and production risk.
